GlaxoSmithKline
GSK
#287
Rank
ยฃ55.05 B
Marketcap
ยฃ26.98
Share price
0.77%
Change (1 day)
-5.55%
Change (1 year)

Operating Margin for GlaxoSmithKline (GSK)

Operating Margin as of November 2024 (TTM): 10.36%

According to GlaxoSmithKline's latest financial reports and stock price the company's current Operating Margin is 10.36%. At the end of 2023 the company had an Operating Margin of 22.39%.

Operating Margin history for GlaxoSmithKline from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202322.39%1.71%
202222.01%24.58%
202117.67%-28.49%
202024.71%17.46%
201921.03%18%
201817.83%26.25%
201714.12%48.26%
20169.52%-79.77%
201547.07%195%
201415.96%-42.75%
201327.87%0.09%
201227.85%-9.79%
201130.87%122.33%
201013.88%-54.59%
200930.58%-0.75%
200830.81%-14.58%
200736.06%7.28%
200633.62%1901.06%
20051.68%-94.17%
200428.80%-3.39%
200329.81%10.7%
200226.93%-9.4%
200129.72%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
15.05% 45.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.80%-82.63%๐Ÿ‡บ๐Ÿ‡ธ USA
3.14%-69.69%๐Ÿ‡บ๐Ÿ‡ธ USA
25.49% 146.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
15.40% 48.65%๐Ÿ‡ซ๐Ÿ‡ท France
-3.93%-137.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-1.88%-118.15%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.